Default object view. Click to create a custom template, Node ID: 71457, Object ID: 44283

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: result...

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

No relation

Yes

No relation

No

07/03/2014 5:36 pm